USPTO serial 87230623
FULL SUN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with FULL SUN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
Jonathan A. Hyman Knobbe Martens Olson and Bear, LLP2040 Main Street, 14th FloorIRVINE, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Dietary and nutritional supplements none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated oils none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Medicated confectionary none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Dietary and nutritional supplements all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Medicated oils all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Medicated confectionary all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Dietary and nutritional supplements all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Medicated oils all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Medicated confectionary all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Dietary and nutritional supplements all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated oils all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated confectionary all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Dietary and nutritional supplements all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated oils all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated confectionary all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Dietary and nutritional supplements all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated oils all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Medicated confectionary all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Topical analgesics, tinctures, namely, herb extracts, and herbal anti-inflammatory salves, all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Dietary and nutritional supplements all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Medicated edible products, namely, candy, chocolates, confections, cookies, crackers, snack foods in the nature of snack bars, snack mixes, and nut and seed-based snack foods, and grain based snack foods all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Medicated oils all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Medicated confectionary all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Herbal hemp oil, other than essential oils, for therapeutic and medical purposes and herbal hemp seed oil for therapeutic and medical purposes all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; and Pharmaceutical preparations, namely, herbal sprays and oils, other than essential oils, in whole or significant part for relief of aches, pains, and anxiety, all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD | ACTIVE | — |
| 034 | Electronic vaporizer cartomizers sold empty; Electronic cigarette atomizers sold empty; Electronic cigarette refill cartridges sold empty; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges sold empty; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges and atomizers and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Oral vaporizers for medical purposes, none of the foregoing containing cannabis, hemp, industrial hemp, CBD, or cannabidiol oil; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Oral vaporizers medical purposes, all of the foregoing being comprised in significant part of sterilized hemp seeds and mature hemp stalk, both being derived solely from hemp having a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and containing no other cannabis ingredients or CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Oral vaporizers for medical purposes, all of the foregoing containing hulled hemp seeds, hemp seed protein and hemp seed oil, all derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis and not containing any other cannabis ingredients or CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Oral vaporizers for medical purposes, all of the foregoing containing industrial hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Oral vaporizers for medical purposes, all of the foregoing containing cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Oral vaporizers for medical purposes, all of the foregoing containing cannabis and hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, being chemical flavorings in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Electronic vaporizer cartomizers being combination electronic cigarette refill cartridges, atomizers, and refill liquid solutions, other than essential oils, in liquid form used to refill electronic cigarette cartridges distributed as a unit, all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD; Oral vaporizers for medical purposes, all of the foregoing containing hemp solely with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis, and also containing only trace amounts of naturally occurring CBD and none of the foregoing containing added CBD | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 1, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 1, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 15, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 23, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 11, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 23, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 9, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 9, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 9, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 9, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 3, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 3, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 3, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 3, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 8, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 15, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2016 | NWAP | NEW APPLICATION ENTERED | — |